萬邦德(002082.SZ):子公司擬與光塵健康科技共設合資公司 生產輕奢非醫用口罩、廣吿定製口罩
格隆匯12月1日丨萬邦德(002082.SZ)公佈,公司於2021年11月30日召開第八屆董事會第十四次會議,審議通過了《關於全資子公司温嶺市萬邦德健康科技有限公司對外投資設立合資子公司的議案》。
公司全資子温嶺市萬邦德健康科技有限公司(簡稱“萬邦德健康科技”)與常州光塵健康科技有限公司(簡稱“光塵健康科技”)簽署合作協議合資設立温嶺萬邦德防護用品有限公司(暫定名以工商核准為準,簡稱“合資公司”)生產輕奢非醫用口罩、廣吿定製口罩,合資公司註冊資本500萬元,萬邦德健康科技以貨幣出資255萬元,佔合資公司註冊資本的51%;光塵健康科技以貨幣出資245萬元,佔合資公司註冊資本的49%。
光塵健康科技負責組建管理團隊負責公司生產與銷售,承諾合資公司未來扣非淨利潤指標:2022年2000萬,2023年2500萬,2024年3125萬。若截至2022年12月31日,合資公司已實現2022年業績指標,萬邦德健康科技及其關聯方約定以現金收購光塵健康科技所持合資公司49%的股權,收購定價參照有證券資質評估機構按收益法評估值協商確定(屆時按評估2023年預測扣非淨利潤計PE倍數不低於10倍)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.